Butyrylcholinesterase variants and methods of use
Abstract
The invention provides four butyrylcholinesterase variants having increased cocaine hydrolysis activity as well as the corresponding encoding nucleic acids. The invention also provides libraries comprising butyrylcholinesterase variants having at least one amino acid alteration in one or more regions of butyrylcholinesterase and further having at least one butyrylcholinesterase variant exhibiting enhanced cocaine hydrolysis activity compared to butyrylcholinesterase. The invention further provides methods of hydrolyzing a cocaine-based butyrylcholinesterase substrate as well as methods of treating a cocaine-induced condition.
Claims
exact text as granted — not AI-modified1 - 3 . (canceled)
4 . A butyrylcholinesterase variant comprising the amino acid sequence shown as SEQ ID NO: 4.
5 . The butyrylcholinesterase variant of claim 4 , having a four-fold increase in cocaine hydrolysis activity.
6 . A nucleic acid encoding a butyrylcholinesterase variant comprising the nucleic acid sequence shown as SEQ ID NO: 3.
7 - 39 . (canceled)Join the waitlist — get patent alerts
Track US2006063248A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.